Clinuvel Pharmaceuticals Limited ( CLVLF) - Key Metrics
CLVLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $1.15 | $0.47 | $0.49 | $0.46 |
| 2026Q2 | $0.74 | $0.21 | $0.25 | $0.25 |
| 2025Q4 | $1.19 | $0.44 | $0.56 | $0.55 |
| 2025Q2 | $0.71 | $0.28 | $0.26 | $0.26 |
| 2024Q4 | $1.11 | $0.49 | $0.21 | $0.21 |
CLVLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | 4.69 |
| 2026Q2 | 24.00% | 13.73 |
| 2025Q4 | 0.00% | 6.23 |
| 2025Q2 | 17.79% | 12.19 |
| 2024Q4 | 0% | 7.74 |
CLVLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 5.22% | 0% |
| 2026Q2 | 2.14% | 0.43% |
| 2025Q4 | 5.04% | 0.00% |
| 2025Q2 | 1.91% | 0.36% |
| 2024Q4 | 1.36% | 0% |
CLVLF
Price: $5.38
Dividend Yield: 0.61%
Forward Dividend Yield: 0.67%
Payout Ratio: 7.08%
Dividend Per Share: 0.04 USD
Earnings Per Share: 0.48 USD
P/E Ratio: 12.33
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 297.4 million
Average Dividend Frequency: 1
Years Paying Dividends: 9
DGR3: 30.00%
DGR5: 30.00%